The findings come from a congressional investigation into drug distributors and their potential failure to report suspicious prescription activity. The report, in particular, focused on the disparity between what AmerisourceBergen and McKesson flagged. The two distributors shipped nearly identical volumes of opioids to Missouri, but the number of suspicious orders each company reported were nowhere close: 224 from AmerisourceBergen and 16,714 from McKesson.

from Kaiser Health News https://ift.tt/2mdxEUk

Related Posts:

0 comments:

Post a Comment

Popular Posts